The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis

Human Brain Mapping

Volumn 33, Issue 12, 2012, Pages 2802-2814

  Gelineau Morel, Rose ^a,b   Tomassini, Valentina ^a,c   Jenkinson, Mark ^a   Johansen Berg, Heidi ^a   Matthews, Paul M ^a,d,e   Palace, Jacqueline ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d GLAXOSMITHKLINE   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Brain atrophy; Gray matter segmentation; Lesion filling; MRI; Multiple sclerosis; White matter lesions

Indexed keywords

ADULT; ARTICLE; AUTOMATED GRAY MATTER SEGMENTATION; AUTOMATION; CLINICAL ARTICLE; DEEP GRAY MATTER; DIAGNOSTIC ERROR; FEMALE; GRAY MATTER; GRAY MATTER VOLUME; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIMULATION; VOXEL BASED MORPHOMETRY; WHITE MATTER LESION;

ADULT; ATROPHY; AXONS; BRAIN; BRAIN MAPPING; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; NERVE FIBERS, UNMYELINATED; ORGAN SIZE;

EID: 84868654177     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.21402     Document Type: Article

References (41)

1. Amadio S, Montilli C, Magliozzi R, Bernardi G, Reynolds R, Volonte C (2010): P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis. Cereb Cortex 20: 1263-1273.
2. Appelman AP, Vincken KL, van der Graaf Y, Vlek AL, Witkamp TD, Mali WP, Geerlings MI (2010): White matter lesions and lacunar infarcts are independently and differently associated with brain atrophy: The SMART-MR study. Cerebrovasc Dis 29: 28-35.
3. Bagnato F, Jeffries N, Richert ND, Stone RD, Ohayon JM, McFarland HF, Frank JA. (2003): Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. Brain 126(Part 8): 1782-1789.
4. Barkhof F, Calabresi PA, Miller DH, Reingold SC (2009): Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol 5: 256-266.
5. Bendfeldt K, Blumhagen JO, Egger H, Loetscher P, Denier N, Kuster P, Traud S, Mueller-Lenke N, Naegelin Y, Gass A, Hirsch J, Kappos L, Nichols TE, Radue EW, Borgwardt SJ, (2010): Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing-remitting multiple sclerosis. Hum Brain Mapp 31: 1542-1555.
6. Benjamini Y, Yekutieli D (2005): Quantitative trait Loci analysis using the false discovery rate. Genetics 171: 783-790.
7. Bo L, Vedeler CA, Nyland HI, Trapp BD, Mork SJ (2003): Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 62: 723-732.
8. Brex PA, Parker GJ, Leary SM, Molyneux PD, Barker GJ, Davie CA, Thompson AJ, Miller DH (2000): Lesion heterogeneity in multiple sclerosis: A study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations. J Neurol Neurosurg Psychiatry 68: 627-632.
9. Ceccarelli A, Rocca MA, Pagani E, Colombo B, Martinelli V, Comi G, Filippi M (2008): A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes. Neuroimage 42: 315-322.
10. Ceccarelli A, Rocca MA, Valsasina P, Rodegher M, Pagani E, Falini A, Comi G, Filippi M (2009): A multiparametric evaluation of regional brain damage in patients with primary progressive multiple sclerosis. Hum Brain Mapp 30: 3009-3019.
11. Chard DT, Jackson JS, Miller DH, Wheeler-Kingshott CA (2010): Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes. J Magn Reson Imaging 32: 223-228.
12. Chard DT, Parker GJ, Griffin CM, Thompson AJ, Miller DH (2002): The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology. J Magn Reson Imaging 15: 259-267.
13. Chen JT, Narayanan S, Collins DL, Smith SM, Matthews PM, Arnold DL (2004): Relating neocortical pathology to disability progression in multiple sclerosis using MRI. Neuroimage 23: 1168-1175.
14. Chen SC, Chung HW, Liou M (2003): Measurement of volumetric lesion load in multiple sclerosis: Moving from normal- to dirty-appearing white matter. AJNR Am J Neuroradiol 24: 1929-1930.
15. Ciccarelli O, Giugni E, Paolillo A, Mainero C, Gasperini C, Bastianello S, Pozzilli C (1999): Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis. Eur J Neurol 6: 455-459.
16. Cifelli A, Arridge M, Jezzard P, Esiri MM, Palace J, Matthews PM (2002): Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 52: 650-653.
17. Datta S, Tao G, He R, Wolinsky JS, Narayana PA (2009): Improved cerebellar tissue classification on magnetic resonance images of brain. J Magn Reson Imaging 29: 1035-1042.
18. De Stefano N, Narayanan S, Francis GS, Arnaoutelis R, Tartaglia MC, Antel JP, Matthews PM, Arnold DL (2001): Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 58: 65-70.
19. Di Rezze S, Gupta S, Durastanti V, Millefiorini E, Pozzilli C, Bagnato F (2007): An exploratory study on interferon beta dose effect in reducing size of enhancing lesions in multiple sclerosis. Mult Scler 13: 343-347.
20. Geurts JJ, Barkhof F (2008): Grey matter pathology in multiple sclerosis. Lancet Neurol 7: 841-851.
21. Geurts JJ, Bo L, Roosendaal SD, Hazes T, Daniels R, Barkhof F, Witter MP, Huitinga I, van der Valk P (2007): Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 66: 819-827.
22. Henry RG, Shieh M, Amirbekian B, Chung S, Okuda DT, Pelletier D (2009): Connecting white matter injury and thalamic atrophy in clinically isolated syndromes. J Neurol Sci 282(1-2): 61-66.
23. Henry RG, Shieh M, Okuda DT, Evangelista A, Gorno-Tempini ML, Pelletier D (2008): Regional grey matter atrophy in clinically isolated syndromes at presentation. J Neurol Neurosurg Psychiatry 79: 1236-1244.
24. Herz J, Zipp F, Siffrin V (2010): Neurodegeneration in autoimmune CNS inflammation. Exp Neurol 225: 9-17.
25. Klein A, Andersson J, Ardekani BA, Ashburner J, Avants B, Chiang MC, Christensen GE, Collins DL, Gee J, Hellier P, Song JH, Jenkinson M, Lepage C, Rueckert D, Thompson P, Vercauteren T, Woods RP, Mann JJ, Parsey RV (2009): Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage 46: 786-802.
26. Lassmann H (2010): Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models. Exp Neurol 225: 2-8.
27. Lewis EB, Fox NC (2004): Correction of differential intensity inhomogeneity in longitudinal MR images. Neuroimage 23: 75-83.
28. Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ (2002): Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain(Part 8): 1676-1695.
29. Nakamura K, Fisher E (2009): Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patients. Neuroimage 44: 769-776.
30. Nijeholt GJ, van Walderveen MA, Castelijns JA, van Waesberghe JH, Polman C, Scheltens P, Rosier PF, Jongen PJ, Barkhof F (1998): Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain 121(Part 4): 687-697.
31. Patenaude B, Smith S, Kennedy D, Jenkinson M (2011): A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 56:907-922.
32. Pozzilli C, Tomassini V, Marinelli F, Paolillo A, Gasperini C, Bastianello S (2003): Gender gap in multiple sclerosis: magnetic resonance imaging evidence. Eur J Neurol 10: 95-97.
33. Ramasamy DP, Benedict RH, Cox JL, Fritz D, Abdelrahman N, Hussein S, Minagar A, Dwyer MG, Zivadinov R (2009): Extent of cerebellum, subcortical and cortical atrophy in patients with MS: A case-control study. J Neurol Sci 282(1-2): 47-54.
34. Sdika M, Pelletier D (2009): Nonrigid registration of multiple sclerosis brain images using lesion inpainting for morphometry or lesion mapping. Hum Brain Mapp 30: 1060-1067.
35. Sepulcre J, Sastre-Garriga J, Cercignani M, Ingle GT, Miller DH, Thompson AJ (2006): Regional gray matter atrophy in early primary progressive multiple sclerosis: A voxel-based morphometry study. Arch Neurol 63: 1175-1180.
36. Suckling J, Sigmundsson T, Greenwood K, Bullmore ET (1999): A modified fuzzy clustering algorithm for operator independent brain tissue classification of dual echo MR images. Magn Reson Imaging 17: 1065-1076.
37. Tao G, Datta S, He R, Nelson F, Wolinsky JS, Narayana PA (2009): Deep gray matter atrophy in multiple sclerosis: A tensor based morphometry. J Neurol Sci 282(1-2): 39-46.
38. Tomassini V, Palace J (2009): Multiple sclerosis lesions: Insights from imaging techniques. Expert Rev Neurother 9: 1341-1359.
39. Vrenken H, Seewann A, Knol DL, Polman CH, Barkhof F, Geurts JJ (2010): Diffusely abnormal white matter in progressive multiple sclerosis: In vivo quantitative MR imaging characterization and comparison between disease types. AJNR Am J Neuroradiol 31: 541-548.
40. Wegner C, Esiri MM, Chance SA, Palace J, Matthews PM (2006): Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 67: 960-967.
41. Zhang Y, Brady M, Smith S (2001): Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20: 45-57.